These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 15029403

  • 1. Neurohormonal antagonism in heart failure: what is the optimal strategy?
    Sackner-Bernstein JD, Hart D.
    Mt Sinai J Med; 2004 Mar; 71(2):115-26. PubMed ID: 15029403
    [Abstract] [Full Text] [Related]

  • 2. Heart failure: recent advances in prevention and treatment.
    Fonarow GC.
    Rev Cardiovasc Med; 2000 Mar; 1(1):25-33, 54. PubMed ID: 12457149
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An approach to heart failure and diabetes mellitus.
    Fonarow GC.
    Am J Cardiol; 2005 Aug 22; 96(4A):47E-52E. PubMed ID: 16098844
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 22; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G.
    Ital Heart J; 2004 Dec 22; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.
    Metra M, Nodari S, D'Aloia A, Madureri A, Rosselli F, Bontempi L, Zanini R, Dei Cas L.
    Eur Heart J; 1998 Feb 22; 19 Suppl B():B25-35. PubMed ID: 9519349
    [Abstract] [Full Text] [Related]

  • 18. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN, Mareev VIu, Skvortsov AA.
    Ter Arkh; 2008 Feb 22; 80(9):5-12. PubMed ID: 19555028
    [No Abstract] [Full Text] [Related]

  • 19. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA, Gheorghiade M.
    Cardiol Clin; 2008 Feb 22; 26(1):23-40, vi. PubMed ID: 18312903
    [Abstract] [Full Text] [Related]

  • 20. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
    Mota T.
    Rev Port Cardiol; 2001 Mar 22; 20 Suppl 3():13-5. PubMed ID: 11409069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.